Trials / Unknown
UnknownNCT05702996
Multicenter, Uncontrolled Pilot Study Evaluating the Efficacy of Eculizumab in the Treatment of Gemcitabine-induced Thrombotic Microangiopathies
- Status
- Unknown
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 10 (estimated)
- Sponsor
- University Hospital, Rouen · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The main objective of this prospective multisite trial is to study the evolution of TMA (thrombotic microangiopathy) induced by gemcitabin and treated by eculizumab.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Eculizumab administration | Patient with Thrombotic microangiopathies induced by gemcitabine will be treat with Eculizumab |
Timeline
- Start date
- 2023-03-01
- Primary completion
- 2025-09-01
- Completion
- 2025-09-01
- First posted
- 2023-01-27
- Last updated
- 2023-01-27
Locations
2 sites across 1 country: France
Source: ClinicalTrials.gov record NCT05702996. Inclusion in this directory is not an endorsement.